DexTech Medical AB (XSAT:DEX) Other Stockholders Equity : kr27.51 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is DexTech Medical AB Other Stockholders Equity?

DexTech Medical AB's Other Stockholders Equity for the quarter that ended in Dec. 2024 was kr27.51 Mil.

DexTech Medical AB's quarterly Other Stockholders Equity increased from Jun. 2024 (kr10.91 Mil) to Sep. 2024 (kr28.47 Mil) but then declined from Sep. 2024 (kr28.47 Mil) to Dec. 2024 (kr27.51 Mil).

DexTech Medical AB's annual Other Stockholders Equity increased from Jun. 2022 (kr3.57 Mil) to Jun. 2023 (kr9.21 Mil) and increased from Jun. 2023 (kr9.21 Mil) to Jun. 2024 (kr10.91 Mil).

DexTech Medical AB Other Stockholders Equity Historical Data

The historical data trend for DexTech Medical AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexTech Medical AB Other Stockholders Equity Chart

DexTech Medical AB Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Stockholders Equity

Get a 7-Day Free Trial

6.97

3.48

3.57

9.21

10.91

DexTech Medical AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															32.32	30.90	10.91	28.47	27.51

DexTech Medical AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

DexTech Medical AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of DexTech Medical AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

DexTech Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DexTech Medical AB (XSAT:DEX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37

Website

https://www.dextechmedical.com

DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a well built clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.